NASDAQ · NMAD
Nomad Power Solutions, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for NMAD: Nov 11, 2026
Nomad Power Solutions, Inc. Common Stock is estimated to report earnings on 11/11/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.33.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Quiver Quantitative · InvestorPlace- RTTNews · Jul 6, 11:12 AM EDTLixte Completes Rebrand To NOMAD Power Solutions; Starts Trading As NMAD(RTTNews) – NOMAD Power Solutions, Inc. (NMAD), formerly Lixte Biotechnology Holdings, Inc. (LIXT), announced on Monday the completion of its corporate name change.
- RTTNews · Jun 1, 11:07 PM EDTTop Biotech Gainers: TTRX Turns Heads, LIXT Shifts To AI Energy, CNXU Update, QTRX, TRAX On Watch(RTTNews) – Monday's top gainers include Turn Therapeutics following its interim analysis findings from an atopic dermatitis study; Conexeu Science on progress in its B.R.E.A.S.T. bioprinting program; LIXTE Biotechnology and its strategic transformation; and Quanterix amid inside
- RTTNews · Sep 11, 12:32 AM EDTAfter-Hours Biotech Gainers: Insider Buys, Trial Updates, And Strategic Deals Fuel Momentum(RTTNews) – Biotech stocks are showing renewed momentum, with several small-cap names posting notable after-hours gains and attracting investor attention. From insider buying and strategic partnerships to clinical trial progress and bold financial moves, companies like Nautilus B
- Quiver Quantitative · Jul 16, 8:13 AM EDTLIXTE Biotechnology Holdings, Inc. Regains Nasdaq Compliance Following Successful Capital RaiseLIXTE Biotechnology has regained Nasdaq compliance after raising $6.5 million in funding, supporting its cancer drug development efforts.
- Quiver Quantitative · Jul 8, 4:15 PM EDTLixte Biotechnology Holdings, Inc. Closes $1.5 Million Registered Direct Offering of Common StockLixte Biotechnology Holdings raised $1.5 million through a registered direct offering of shares to accredited investors.
- Quiver Quantitative · Jul 1, 4:23 PM EDTLixte Biotechnology Holdings, Inc. Announces $5 Million Private Placement of Common Stock and Preferred SharesLixte Biotechnology secures $5 million investment through shares and warrants, funding general corporate purposes and cancer research.
- RTTNews · Mar 27, 2:16 PM EDTLIXTE Biotechnology Updates Progress On LB-100 In Ovarian And Colorectal Cancer Trials(RTTNews) – LIXTE Biotechnology Holdings, Inc. (LIXT), on Thursday, announced the latest progress with its proprietary compound, LB-100, for the treatment of ovarian and colorectal cancer.
- Quiver Quantitative · Feb 25, 8:42 AM ESTLIXTE Biotechnology Teams Up with Lurie Cancer Center to Initiate Clinical Trial of LB-100 and GSK’s Dostarlimab for Ovarian Clear Cell CancerLurie Cancer Center initiates trial combining LIXTE's LB-100 and GSK's Dostarlimab for ovarian clear cell cancer treatment.
- Quiver Quantitative · Feb 13, 10:40 AM ESTLIXTE Biotechnology Holdings, Inc. Completes Registered Direct Offering and Private Placement Raising Approximately $1.05 MillionLIXTE Biotechnology completed a direct offering of 434,784 shares at $2.415 each, raising approximately $1,050,000 for corporate purposes.
- Quiver Quantitative · Feb 10, 5:10 PM ESTLIXTE Biotechnology Holdings, Inc. Withdraws Registration Statement for Proposed Public OfferingLIXTE Biotechnology Holdings withdraws its SEC registration statement for a public offering, citing changed plans.
- RTTNews · Jun 14, 10:19 AM EDTLixte, Roche, Netherlands Cancer Institute Collaborate For Colon Cancer Trial; Stock Up(RTTNews) – Lixte Biotechnology Holdings, Inc. (LIXT), Friday announced a partnership with Swiss healthcare company Roche Holding AG (RHHBY) and the Netherlands Cancer Institute to conduct a new clinical trial for immune therapy unresponsive metastatic colon cancer.
- InvestorPlace · Apr 12, 3:20 PM EDTLIXT Stock Gets 200%+ Lift, Don’t Get Caught on the Way DownInvestorPlace – Stock Market News, Stock Advice & Trading Tips
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Nomad Power Solutions, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.